Search
Add filters:
Use filters to refine the search results.
Item hits:
| Issue Date | Title | Author(s) |
|---|---|---|
| Mar-2016 | Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis | Sia, Daniela; Villanueva, Augusto; Friedman, Scott L.; Llovet i Bayer, Josep Maria |
| 23-Jan-2017 | Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity | Moeini, Agrin; Sia, Daniela; Zhang, Zhongyang; Campreciós Figueras, Genís; Stueck, Ashley; Dong, Hui; Montal, Robert; Torrens, Laura; Martínez Quetglas, Iris; Fiel, Maria Isabel; Hao, Ke; Villanueva, Augusto; Thung, Swan N.; Schwartz, Myron; Llovet i Bayer, Josep Maria |
| 25-Jan-2017 | Objective response by mRECIST as a predictor and potential surrogate end point of overall survival in advanced HCC | Lencioni, Riccardo; Montal, Robert; Torre, Ferran; Park, Joong-Won; Decaens, Thomas; Raoul, Jean-Luc; Kudo, Masatoshi; Chang, Charissa Y.; Ríos, José; Boige, Valerie; Assenat, Eric; Kang, Yoon-Koo; Lim, Ho-Yeong; Walters, Ian; Llovet i Bayer, Josep Maria |
| 24-Aug-2017 | Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma | Torrecilla, Sara; Harrington, Andrew N.; Sia, Daniela; Zhang, Zhongyang; Cabellos, Laia; Cornella, Helena; Moeini, Agrin; Campreciós Figueras, Genís; Leow, Wei-Quiang; Fiel, Maria Isabel; Hao, Ke; Bassaganyas, Laia; Mahajan, Milind; Thung, Swan N.; Villanueva, Augusto; Florman, Sander; Schwartz, Myron; Llovet i Bayer, Josep Maria |
| 15-Nov-2017 | Pilot study of living donor liver transplantation for patients with HCC exceeding Milan criteria | Llovet i Bayer, Josep Maria; Pavel, Mihai; Rimola, Jordi; Diaz, Maria Alba; Colmenero, Jordi; Saavedra, David; Fondevila Campo, Constantino; Ayuso Colella, Carmen; Fuster Obregón, Josep; Ginès i Gibert, Pere; Bruix Tudó, Jordi; García-Valdecasas Salgado, Juan Carlos |
| 20-Mar-2014 | Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?' | Llovet i Bayer, Josep Maria; Johnson, Philip J. |
| 9-Jul-2019 | Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials | Montal, Robert; Andreu Oller, Carmen; Bassaganyas, Laia; Esteban Fabró, Roger; Moran, Sebastian; Montironi, Carla; Moeini, Agrin; Pinyol, Roser; Peix, Judit; Cabellos, Laia; Villanueva, Augusto; Sia, Daniela; Mazzaferro, Vincenzo; Esteller, Manel; Llovet i Bayer, Josep Maria |
| 1-Apr-2015 | Unique genomic profile of fibrolamellar hepatocellular carcinoma | Cornella, Helena; Alsinet, Clara; Sayols, Sergi; Zhang, Zhongyang; Hao, Ke; Cabellos, Laia; Hoshida, Yujin; Vila Casadesús, Maria; Villanueva, Augusto; Thung, Swan N.; Ward, Stephen C.; Rodríguez-Carunchio, Leonardo; Imbeaud, Sandrine; Lachenmayer, Anja; Quaglia, Alberto; Nagorney David M.; Minguez, Beatriz; Carrilho, Flair José; Robert, Lewis R.; Mazzaferro, Vincenzo; Schwartz, Myron; Esteller, Manel; Heaton, Nigel D.; Zucman-Rossi, Jessica; Llovet i Bayer, Josep Maria |
| 14-Jun-2018 | Liver Cancer Disparities in New York City: A neighborhood wiew of risk and harm reduction factors | Kamath, Geetanjali R.; Taioli, Emanuela; Egorva, Natalia N.; Llovet i Bayer, Josep Maria; Perumalswami, Ponni V.; Weiss, Jeffrey J.; Schwartz, Myron; Ewala, Stanley; Bickell, Nina A. |
| 13-Nov-2020 | Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2 | Kudo, Masatoshi; Galle, Peter R.; Brandi, Giovanni; Kang, Yoon Koo; Yen, Chia Jui; Finn, Richard S.; Llovet i Bayer, Josep Maria; Assenat, Eric; Merle, Philippe; Chan, Stephen L.; Palmer, Daniel H.; Ikeda, Masafumi; Yamashita, Tatsuya; Vogel, Arndt; Huang, Yi Hsiang; Abada, Paolo; Yoshikawa, Reigetsu; Shinozaki, Kenta; Wang, Chunxiao; Widau, Ryan C.; Zhu, Andrew X. |
Discover
Subject